Hormone therapy as a management strategy for lung metastasis after 5 years of endometrial cancer: A case report and literature review


    loading  Checking for direct PDF access through Ovid

Abstract

Rationale:Endometrial cancer patients with lung metastases are rare, and more rarely with long-term management of progesterone after recurrence.Patient concerns:Informed consent of the patients and their families.Diagnoses:Endometrial cancer (IVB) (Refer to 2009 FIGO stag of endometrial cancer).Interventions:the patient was treated with Megestrol Acetate Dispersible Tablets (trade name Yilizhi), 160 mg, orally, once daily, without interruption.Outcomes:The patient has been treated with progesterone therapy for stable conditions and her survival time is already roughly a decade (December 2006–October 2016).Lessons:Hormone therapy may as a long-term management for hormone receptor-positive patients with recurrent endometrial cancer.

    loading  Loading Related Articles